Tag: Zhou Hanshuo
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
A-list partners share their personal rituals for sustaining performance in increasingly demanding work environments